Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai

The objective of this study is to assess the incremental cost-effectiveness of 2 projects

Abstract

METHODS: Costs were assessed from a societal perspective. The primary measure of effectiveness was the treatment completion rate. The incremental cost-effectiveness ratio was calculated as the additional cost of the intervention divided by the additional percentage of patients completing treatment compared to controls.

RESULTS: Post intervention, the treatment completion rates in the COMDIS and Global Fund projects were respectively 89% and 88%, 17% and 16% higher than in the control district (76%). For one additional per cent of patients to complete treatment, the additional cost of the COMDIS intervention was US$1891, 91% lower than that of the Global Fund intervention (US$21 904).

CONCLUSION: The intervention that addressed the financial barriers of poor patients was more cost-effective than the comprehensive intervention that provided assistance to both patients and providers. Further study is needed to understand the process of interventions prior to wider scale-up.

This research is supported by the Department for International Development’s COMDIS–HSD Programme which is led by the University of Leeds

Citation

Zou, G.; Wei, X.; Witter, S.; Yin, J.; Walley, J.; Liu, S.; Yang, H.; Chen, J.; Tian, G.; Mei, J. Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai. International Journal of Tuberculosis and Lung Disease (2013) 17 (8) 1056-1064. [DOI: 10.5588/ijtld.12.0799]

Incremental cost-effectiveness of improving treatment results among migrant tuberculosis patients in Shanghai

Published 1 August 2013